Global External Neuromodulation Market Research Report 2024(Status and Outlook)
![](/report_cover/11711/global-external-neuromodulation-market-research-report-2024status-n-outlook_en.gif)
Report Overview
This report provides a deep insight into the global External Neuromodulation market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global External Neuromodulation Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the External Neuromodulation market in any manner.
Global External Neuromodulation Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Medtronic, Inc. (US)
Boston Scientific Corporation (US)
St. Jude Medical, Inc. (US)
Synapse Biomedical, Inc. (US)
Nevro Corporation (US)
Neurosigma, Inc. (US)
Neuropace, Inc. (US)
Neuronetics, Inc. (US)
Cyberonics, Inc. (US)
BioControl Medical (Israel)
Market Segmentation (by Type)
Transcutaneous Electrical Nerve Stimulation
Transcranial Magnetic Stimulation
Respiratory Electrical Stimulation
Market Segmentation (by Application)
Spinal Cord Stimulation
Deep Brain Stimulation
Sacral Nerve Stimulation
Others
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the External Neuromodulation Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
This report provides a deep insight into the global External Neuromodulation market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global External Neuromodulation Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the External Neuromodulation market in any manner.
Global External Neuromodulation Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Medtronic, Inc. (US)
Boston Scientific Corporation (US)
St. Jude Medical, Inc. (US)
Synapse Biomedical, Inc. (US)
Nevro Corporation (US)
Neurosigma, Inc. (US)
Neuropace, Inc. (US)
Neuronetics, Inc. (US)
Cyberonics, Inc. (US)
BioControl Medical (Israel)
Market Segmentation (by Type)
Transcutaneous Electrical Nerve Stimulation
Transcranial Magnetic Stimulation
Respiratory Electrical Stimulation
Market Segmentation (by Application)
Spinal Cord Stimulation
Deep Brain Stimulation
Sacral Nerve Stimulation
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the External Neuromodulation Market
- Overview of the regional outlook of the External Neuromodulation Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the External Neuromodulation Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of External Neuromodulation
1.2 Key Market Segments
1.2.1 External Neuromodulation Segment by Type
1.2.2 External Neuromodulation Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 EXTERNAL NEUROMODULATION MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global External Neuromodulation Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global External Neuromodulation Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 EXTERNAL NEUROMODULATION MARKET COMPETITIVE LANDSCAPE
3.1 Global External Neuromodulation Sales by Manufacturers (2019-2024)
3.2 Global External Neuromodulation Revenue Market Share by Manufacturers (2019-2024)
3.3 External Neuromodulation Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global External Neuromodulation Average Price by Manufacturers (2019-2024)
3.5 Manufacturers External Neuromodulation Sales Sites, Area Served, Product Type
3.6 External Neuromodulation Market Competitive Situation and Trends
3.6.1 External Neuromodulation Market Concentration Rate
3.6.2 Global 5 and 10 Largest External Neuromodulation Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 EXTERNAL NEUROMODULATION INDUSTRY CHAIN ANALYSIS
4.1 External Neuromodulation Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF EXTERNAL NEUROMODULATION MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 EXTERNAL NEUROMODULATION MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global External Neuromodulation Sales Market Share by Type (2019-2024)
6.3 Global External Neuromodulation Market Size Market Share by Type (2019-2024)
6.4 Global External Neuromodulation Price by Type (2019-2024)
7 EXTERNAL NEUROMODULATION MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global External Neuromodulation Market Sales by Application (2019-2024)
7.3 Global External Neuromodulation Market Size (M USD) by Application (2019-2024)
7.4 Global External Neuromodulation Sales Growth Rate by Application (2019-2024)
8 EXTERNAL NEUROMODULATION MARKET SEGMENTATION BY REGION
8.1 Global External Neuromodulation Sales by Region
8.1.1 Global External Neuromodulation Sales by Region
8.1.2 Global External Neuromodulation Sales Market Share by Region
8.2 North America
8.2.1 North America External Neuromodulation Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe External Neuromodulation Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific External Neuromodulation Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America External Neuromodulation Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa External Neuromodulation Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Medtronic, Inc. (US)
9.1.1 Medtronic, Inc. (US) External Neuromodulation Basic Information
9.1.2 Medtronic, Inc. (US) External Neuromodulation Product Overview
9.1.3 Medtronic, Inc. (US) External Neuromodulation Product Market Performance
9.1.4 Medtronic, Inc. (US) Business Overview
9.1.5 Medtronic, Inc. (US) External Neuromodulation SWOT Analysis
9.1.6 Medtronic, Inc. (US) Recent Developments
9.2 Boston Scientific Corporation (US)
9.2.1 Boston Scientific Corporation (US) External Neuromodulation Basic Information
9.2.2 Boston Scientific Corporation (US) External Neuromodulation Product Overview
9.2.3 Boston Scientific Corporation (US) External Neuromodulation Product Market Performance
9.2.4 Boston Scientific Corporation (US) Business Overview
9.2.5 Boston Scientific Corporation (US) External Neuromodulation SWOT Analysis
9.2.6 Boston Scientific Corporation (US) Recent Developments
9.3 St. Jude Medical, Inc. (US)
9.3.1 St. Jude Medical, Inc. (US) External Neuromodulation Basic Information
9.3.2 St. Jude Medical, Inc. (US) External Neuromodulation Product Overview
9.3.3 St. Jude Medical, Inc. (US) External Neuromodulation Product Market Performance
9.3.4 St. Jude Medical, Inc. (US) External Neuromodulation SWOT Analysis
9.3.5 St. Jude Medical, Inc. (US) Business Overview
9.3.6 St. Jude Medical, Inc. (US) Recent Developments
9.4 Synapse Biomedical, Inc. (US)
9.4.1 Synapse Biomedical, Inc. (US) External Neuromodulation Basic Information
9.4.2 Synapse Biomedical, Inc. (US) External Neuromodulation Product Overview
9.4.3 Synapse Biomedical, Inc. (US) External Neuromodulation Product Market Performance
9.4.4 Synapse Biomedical, Inc. (US) Business Overview
9.4.5 Synapse Biomedical, Inc. (US) Recent Developments
9.5 Nevro Corporation (US)
9.5.1 Nevro Corporation (US) External Neuromodulation Basic Information
9.5.2 Nevro Corporation (US) External Neuromodulation Product Overview
9.5.3 Nevro Corporation (US) External Neuromodulation Product Market Performance
9.5.4 Nevro Corporation (US) Business Overview
9.5.5 Nevro Corporation (US) Recent Developments
9.6 Neurosigma, Inc. (US)
9.6.1 Neurosigma, Inc. (US) External Neuromodulation Basic Information
9.6.2 Neurosigma, Inc. (US) External Neuromodulation Product Overview
9.6.3 Neurosigma, Inc. (US) External Neuromodulation Product Market Performance
9.6.4 Neurosigma, Inc. (US) Business Overview
9.6.5 Neurosigma, Inc. (US) Recent Developments
9.7 Neuropace, Inc. (US)
9.7.1 Neuropace, Inc. (US) External Neuromodulation Basic Information
9.7.2 Neuropace, Inc. (US) External Neuromodulation Product Overview
9.7.3 Neuropace, Inc. (US) External Neuromodulation Product Market Performance
9.7.4 Neuropace, Inc. (US) Business Overview
9.7.5 Neuropace, Inc. (US) Recent Developments
9.8 Neuronetics, Inc. (US)
9.8.1 Neuronetics, Inc. (US) External Neuromodulation Basic Information
9.8.2 Neuronetics, Inc. (US) External Neuromodulation Product Overview
9.8.3 Neuronetics, Inc. (US) External Neuromodulation Product Market Performance
9.8.4 Neuronetics, Inc. (US) Business Overview
9.8.5 Neuronetics, Inc. (US) Recent Developments
9.9 Cyberonics, Inc. (US)
9.9.1 Cyberonics, Inc. (US) External Neuromodulation Basic Information
9.9.2 Cyberonics, Inc. (US) External Neuromodulation Product Overview
9.9.3 Cyberonics, Inc. (US) External Neuromodulation Product Market Performance
9.9.4 Cyberonics, Inc. (US) Business Overview
9.9.5 Cyberonics, Inc. (US) Recent Developments
9.10 BioControl Medical (Israel)
9.10.1 BioControl Medical (Israel) External Neuromodulation Basic Information
9.10.2 BioControl Medical (Israel) External Neuromodulation Product Overview
9.10.3 BioControl Medical (Israel) External Neuromodulation Product Market Performance
9.10.4 BioControl Medical (Israel) Business Overview
9.10.5 BioControl Medical (Israel) Recent Developments
10 EXTERNAL NEUROMODULATION MARKET FORECAST BY REGION
10.1 Global External Neuromodulation Market Size Forecast
10.2 Global External Neuromodulation Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe External Neuromodulation Market Size Forecast by Country
10.2.3 Asia Pacific External Neuromodulation Market Size Forecast by Region
10.2.4 South America External Neuromodulation Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of External Neuromodulation by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global External Neuromodulation Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of External Neuromodulation by Type (2025-2030)
11.1.2 Global External Neuromodulation Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of External Neuromodulation by Type (2025-2030)
11.2 Global External Neuromodulation Market Forecast by Application (2025-2030)
11.2.1 Global External Neuromodulation Sales (K Units) Forecast by Application
11.2.2 Global External Neuromodulation Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of External Neuromodulation
1.2 Key Market Segments
1.2.1 External Neuromodulation Segment by Type
1.2.2 External Neuromodulation Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 EXTERNAL NEUROMODULATION MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global External Neuromodulation Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global External Neuromodulation Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 EXTERNAL NEUROMODULATION MARKET COMPETITIVE LANDSCAPE
3.1 Global External Neuromodulation Sales by Manufacturers (2019-2024)
3.2 Global External Neuromodulation Revenue Market Share by Manufacturers (2019-2024)
3.3 External Neuromodulation Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global External Neuromodulation Average Price by Manufacturers (2019-2024)
3.5 Manufacturers External Neuromodulation Sales Sites, Area Served, Product Type
3.6 External Neuromodulation Market Competitive Situation and Trends
3.6.1 External Neuromodulation Market Concentration Rate
3.6.2 Global 5 and 10 Largest External Neuromodulation Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 EXTERNAL NEUROMODULATION INDUSTRY CHAIN ANALYSIS
4.1 External Neuromodulation Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF EXTERNAL NEUROMODULATION MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 EXTERNAL NEUROMODULATION MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global External Neuromodulation Sales Market Share by Type (2019-2024)
6.3 Global External Neuromodulation Market Size Market Share by Type (2019-2024)
6.4 Global External Neuromodulation Price by Type (2019-2024)
7 EXTERNAL NEUROMODULATION MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global External Neuromodulation Market Sales by Application (2019-2024)
7.3 Global External Neuromodulation Market Size (M USD) by Application (2019-2024)
7.4 Global External Neuromodulation Sales Growth Rate by Application (2019-2024)
8 EXTERNAL NEUROMODULATION MARKET SEGMENTATION BY REGION
8.1 Global External Neuromodulation Sales by Region
8.1.1 Global External Neuromodulation Sales by Region
8.1.2 Global External Neuromodulation Sales Market Share by Region
8.2 North America
8.2.1 North America External Neuromodulation Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe External Neuromodulation Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific External Neuromodulation Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America External Neuromodulation Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa External Neuromodulation Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Medtronic, Inc. (US)
9.1.1 Medtronic, Inc. (US) External Neuromodulation Basic Information
9.1.2 Medtronic, Inc. (US) External Neuromodulation Product Overview
9.1.3 Medtronic, Inc. (US) External Neuromodulation Product Market Performance
9.1.4 Medtronic, Inc. (US) Business Overview
9.1.5 Medtronic, Inc. (US) External Neuromodulation SWOT Analysis
9.1.6 Medtronic, Inc. (US) Recent Developments
9.2 Boston Scientific Corporation (US)
9.2.1 Boston Scientific Corporation (US) External Neuromodulation Basic Information
9.2.2 Boston Scientific Corporation (US) External Neuromodulation Product Overview
9.2.3 Boston Scientific Corporation (US) External Neuromodulation Product Market Performance
9.2.4 Boston Scientific Corporation (US) Business Overview
9.2.5 Boston Scientific Corporation (US) External Neuromodulation SWOT Analysis
9.2.6 Boston Scientific Corporation (US) Recent Developments
9.3 St. Jude Medical, Inc. (US)
9.3.1 St. Jude Medical, Inc. (US) External Neuromodulation Basic Information
9.3.2 St. Jude Medical, Inc. (US) External Neuromodulation Product Overview
9.3.3 St. Jude Medical, Inc. (US) External Neuromodulation Product Market Performance
9.3.4 St. Jude Medical, Inc. (US) External Neuromodulation SWOT Analysis
9.3.5 St. Jude Medical, Inc. (US) Business Overview
9.3.6 St. Jude Medical, Inc. (US) Recent Developments
9.4 Synapse Biomedical, Inc. (US)
9.4.1 Synapse Biomedical, Inc. (US) External Neuromodulation Basic Information
9.4.2 Synapse Biomedical, Inc. (US) External Neuromodulation Product Overview
9.4.3 Synapse Biomedical, Inc. (US) External Neuromodulation Product Market Performance
9.4.4 Synapse Biomedical, Inc. (US) Business Overview
9.4.5 Synapse Biomedical, Inc. (US) Recent Developments
9.5 Nevro Corporation (US)
9.5.1 Nevro Corporation (US) External Neuromodulation Basic Information
9.5.2 Nevro Corporation (US) External Neuromodulation Product Overview
9.5.3 Nevro Corporation (US) External Neuromodulation Product Market Performance
9.5.4 Nevro Corporation (US) Business Overview
9.5.5 Nevro Corporation (US) Recent Developments
9.6 Neurosigma, Inc. (US)
9.6.1 Neurosigma, Inc. (US) External Neuromodulation Basic Information
9.6.2 Neurosigma, Inc. (US) External Neuromodulation Product Overview
9.6.3 Neurosigma, Inc. (US) External Neuromodulation Product Market Performance
9.6.4 Neurosigma, Inc. (US) Business Overview
9.6.5 Neurosigma, Inc. (US) Recent Developments
9.7 Neuropace, Inc. (US)
9.7.1 Neuropace, Inc. (US) External Neuromodulation Basic Information
9.7.2 Neuropace, Inc. (US) External Neuromodulation Product Overview
9.7.3 Neuropace, Inc. (US) External Neuromodulation Product Market Performance
9.7.4 Neuropace, Inc. (US) Business Overview
9.7.5 Neuropace, Inc. (US) Recent Developments
9.8 Neuronetics, Inc. (US)
9.8.1 Neuronetics, Inc. (US) External Neuromodulation Basic Information
9.8.2 Neuronetics, Inc. (US) External Neuromodulation Product Overview
9.8.3 Neuronetics, Inc. (US) External Neuromodulation Product Market Performance
9.8.4 Neuronetics, Inc. (US) Business Overview
9.8.5 Neuronetics, Inc. (US) Recent Developments
9.9 Cyberonics, Inc. (US)
9.9.1 Cyberonics, Inc. (US) External Neuromodulation Basic Information
9.9.2 Cyberonics, Inc. (US) External Neuromodulation Product Overview
9.9.3 Cyberonics, Inc. (US) External Neuromodulation Product Market Performance
9.9.4 Cyberonics, Inc. (US) Business Overview
9.9.5 Cyberonics, Inc. (US) Recent Developments
9.10 BioControl Medical (Israel)
9.10.1 BioControl Medical (Israel) External Neuromodulation Basic Information
9.10.2 BioControl Medical (Israel) External Neuromodulation Product Overview
9.10.3 BioControl Medical (Israel) External Neuromodulation Product Market Performance
9.10.4 BioControl Medical (Israel) Business Overview
9.10.5 BioControl Medical (Israel) Recent Developments
10 EXTERNAL NEUROMODULATION MARKET FORECAST BY REGION
10.1 Global External Neuromodulation Market Size Forecast
10.2 Global External Neuromodulation Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe External Neuromodulation Market Size Forecast by Country
10.2.3 Asia Pacific External Neuromodulation Market Size Forecast by Region
10.2.4 South America External Neuromodulation Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of External Neuromodulation by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global External Neuromodulation Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of External Neuromodulation by Type (2025-2030)
11.1.2 Global External Neuromodulation Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of External Neuromodulation by Type (2025-2030)
11.2 Global External Neuromodulation Market Forecast by Application (2025-2030)
11.2.1 Global External Neuromodulation Sales (K Units) Forecast by Application
11.2.2 Global External Neuromodulation Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. External Neuromodulation Market Size Comparison by Region (M USD)
Table 5. Global External Neuromodulation Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global External Neuromodulation Sales Market Share by Manufacturers (2019-2024)
Table 7. Global External Neuromodulation Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global External Neuromodulation Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in External Neuromodulation as of 2022)
Table 10. Global Market External Neuromodulation Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers External Neuromodulation Sales Sites and Area Served
Table 12. Manufacturers External Neuromodulation Product Type
Table 13. Global External Neuromodulation Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of External Neuromodulation
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. External Neuromodulation Market Challenges
Table 22. Global External Neuromodulation Sales by Type (K Units)
Table 23. Global External Neuromodulation Market Size by Type (M USD)
Table 24. Global External Neuromodulation Sales (K Units) by Type (2019-2024)
Table 25. Global External Neuromodulation Sales Market Share by Type (2019-2024)
Table 26. Global External Neuromodulation Market Size (M USD) by Type (2019-2024)
Table 27. Global External Neuromodulation Market Size Share by Type (2019-2024)
Table 28. Global External Neuromodulation Price (USD/Unit) by Type (2019-2024)
Table 29. Global External Neuromodulation Sales (K Units) by Application
Table 30. Global External Neuromodulation Market Size by Application
Table 31. Global External Neuromodulation Sales by Application (2019-2024) & (K Units)
Table 32. Global External Neuromodulation Sales Market Share by Application (2019-2024)
Table 33. Global External Neuromodulation Sales by Application (2019-2024) & (M USD)
Table 34. Global External Neuromodulation Market Share by Application (2019-2024)
Table 35. Global External Neuromodulation Sales Growth Rate by Application (2019-2024)
Table 36. Global External Neuromodulation Sales by Region (2019-2024) & (K Units)
Table 37. Global External Neuromodulation Sales Market Share by Region (2019-2024)
Table 38. North America External Neuromodulation Sales by Country (2019-2024) & (K Units)
Table 39. Europe External Neuromodulation Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific External Neuromodulation Sales by Region (2019-2024) & (K Units)
Table 41. South America External Neuromodulation Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa External Neuromodulation Sales by Region (2019-2024) & (K Units)
Table 43. Medtronic, Inc. (US) External Neuromodulation Basic Information
Table 44. Medtronic, Inc. (US) External Neuromodulation Product Overview
Table 45. Medtronic, Inc. (US) External Neuromodulation Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Medtronic, Inc. (US) Business Overview
Table 47. Medtronic, Inc. (US) External Neuromodulation SWOT Analysis
Table 48. Medtronic, Inc. (US) Recent Developments
Table 49. Boston Scientific Corporation (US) External Neuromodulation Basic Information
Table 50. Boston Scientific Corporation (US) External Neuromodulation Product Overview
Table 51. Boston Scientific Corporation (US) External Neuromodulation Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Boston Scientific Corporation (US) Business Overview
Table 53. Boston Scientific Corporation (US) External Neuromodulation SWOT Analysis
Table 54. Boston Scientific Corporation (US) Recent Developments
Table 55. St. Jude Medical, Inc. (US) External Neuromodulation Basic Information
Table 56. St. Jude Medical, Inc. (US) External Neuromodulation Product Overview
Table 57. St. Jude Medical, Inc. (US) External Neuromodulation Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. St. Jude Medical, Inc. (US) External Neuromodulation SWOT Analysis
Table 59. St. Jude Medical, Inc. (US) Business Overview
Table 60. St. Jude Medical, Inc. (US) Recent Developments
Table 61. Synapse Biomedical, Inc. (US) External Neuromodulation Basic Information
Table 62. Synapse Biomedical, Inc. (US) External Neuromodulation Product Overview
Table 63. Synapse Biomedical, Inc. (US) External Neuromodulation Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Synapse Biomedical, Inc. (US) Business Overview
Table 65. Synapse Biomedical, Inc. (US) Recent Developments
Table 66. Nevro Corporation (US) External Neuromodulation Basic Information
Table 67. Nevro Corporation (US) External Neuromodulation Product Overview
Table 68. Nevro Corporation (US) External Neuromodulation Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Nevro Corporation (US) Business Overview
Table 70. Nevro Corporation (US) Recent Developments
Table 71. Neurosigma, Inc. (US) External Neuromodulation Basic Information
Table 72. Neurosigma, Inc. (US) External Neuromodulation Product Overview
Table 73. Neurosigma, Inc. (US) External Neuromodulation Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Neurosigma, Inc. (US) Business Overview
Table 75. Neurosigma, Inc. (US) Recent Developments
Table 76. Neuropace, Inc. (US) External Neuromodulation Basic Information
Table 77. Neuropace, Inc. (US) External Neuromodulation Product Overview
Table 78. Neuropace, Inc. (US) External Neuromodulation Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Neuropace, Inc. (US) Business Overview
Table 80. Neuropace, Inc. (US) Recent Developments
Table 81. Neuronetics, Inc. (US) External Neuromodulation Basic Information
Table 82. Neuronetics, Inc. (US) External Neuromodulation Product Overview
Table 83. Neuronetics, Inc. (US) External Neuromodulation Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Neuronetics, Inc. (US) Business Overview
Table 85. Neuronetics, Inc. (US) Recent Developments
Table 86. Cyberonics, Inc. (US) External Neuromodulation Basic Information
Table 87. Cyberonics, Inc. (US) External Neuromodulation Product Overview
Table 88. Cyberonics, Inc. (US) External Neuromodulation Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Cyberonics, Inc. (US) Business Overview
Table 90. Cyberonics, Inc. (US) Recent Developments
Table 91. BioControl Medical (Israel) External Neuromodulation Basic Information
Table 92. BioControl Medical (Israel) External Neuromodulation Product Overview
Table 93. BioControl Medical (Israel) External Neuromodulation Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. BioControl Medical (Israel) Business Overview
Table 95. BioControl Medical (Israel) Recent Developments
Table 96. Global External Neuromodulation Sales Forecast by Region (2025-2030) & (K Units)
Table 97. Global External Neuromodulation Market Size Forecast by Region (2025-2030) & (M USD)
Table 98. North America External Neuromodulation Sales Forecast by Country (2025-2030) & (K Units)
Table 99. North America External Neuromodulation Market Size Forecast by Country (2025-2030) & (M USD)
Table 100. Europe External Neuromodulation Sales Forecast by Country (2025-2030) & (K Units)
Table 101. Europe External Neuromodulation Market Size Forecast by Country (2025-2030) & (M USD)
Table 102. Asia Pacific External Neuromodulation Sales Forecast by Region (2025-2030) & (K Units)
Table 103. Asia Pacific External Neuromodulation Market Size Forecast by Region (2025-2030) & (M USD)
Table 104. South America External Neuromodulation Sales Forecast by Country (2025-2030) & (K Units)
Table 105. South America External Neuromodulation Market Size Forecast by Country (2025-2030) & (M USD)
Table 106. Middle East and Africa External Neuromodulation Consumption Forecast by Country (2025-2030) & (Units)
Table 107. Middle East and Africa External Neuromodulation Market Size Forecast by Country (2025-2030) & (M USD)
Table 108. Global External Neuromodulation Sales Forecast by Type (2025-2030) & (K Units)
Table 109. Global External Neuromodulation Market Size Forecast by Type (2025-2030) & (M USD)
Table 110. Global External Neuromodulation Price Forecast by Type (2025-2030) & (USD/Unit)
Table 111. Global External Neuromodulation Sales (K Units) Forecast by Application (2025-2030)
Table 112. Global External Neuromodulation Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. External Neuromodulation Market Size Comparison by Region (M USD)
Table 5. Global External Neuromodulation Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global External Neuromodulation Sales Market Share by Manufacturers (2019-2024)
Table 7. Global External Neuromodulation Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global External Neuromodulation Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in External Neuromodulation as of 2022)
Table 10. Global Market External Neuromodulation Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers External Neuromodulation Sales Sites and Area Served
Table 12. Manufacturers External Neuromodulation Product Type
Table 13. Global External Neuromodulation Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of External Neuromodulation
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. External Neuromodulation Market Challenges
Table 22. Global External Neuromodulation Sales by Type (K Units)
Table 23. Global External Neuromodulation Market Size by Type (M USD)
Table 24. Global External Neuromodulation Sales (K Units) by Type (2019-2024)
Table 25. Global External Neuromodulation Sales Market Share by Type (2019-2024)
Table 26. Global External Neuromodulation Market Size (M USD) by Type (2019-2024)
Table 27. Global External Neuromodulation Market Size Share by Type (2019-2024)
Table 28. Global External Neuromodulation Price (USD/Unit) by Type (2019-2024)
Table 29. Global External Neuromodulation Sales (K Units) by Application
Table 30. Global External Neuromodulation Market Size by Application
Table 31. Global External Neuromodulation Sales by Application (2019-2024) & (K Units)
Table 32. Global External Neuromodulation Sales Market Share by Application (2019-2024)
Table 33. Global External Neuromodulation Sales by Application (2019-2024) & (M USD)
Table 34. Global External Neuromodulation Market Share by Application (2019-2024)
Table 35. Global External Neuromodulation Sales Growth Rate by Application (2019-2024)
Table 36. Global External Neuromodulation Sales by Region (2019-2024) & (K Units)
Table 37. Global External Neuromodulation Sales Market Share by Region (2019-2024)
Table 38. North America External Neuromodulation Sales by Country (2019-2024) & (K Units)
Table 39. Europe External Neuromodulation Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific External Neuromodulation Sales by Region (2019-2024) & (K Units)
Table 41. South America External Neuromodulation Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa External Neuromodulation Sales by Region (2019-2024) & (K Units)
Table 43. Medtronic, Inc. (US) External Neuromodulation Basic Information
Table 44. Medtronic, Inc. (US) External Neuromodulation Product Overview
Table 45. Medtronic, Inc. (US) External Neuromodulation Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Medtronic, Inc. (US) Business Overview
Table 47. Medtronic, Inc. (US) External Neuromodulation SWOT Analysis
Table 48. Medtronic, Inc. (US) Recent Developments
Table 49. Boston Scientific Corporation (US) External Neuromodulation Basic Information
Table 50. Boston Scientific Corporation (US) External Neuromodulation Product Overview
Table 51. Boston Scientific Corporation (US) External Neuromodulation Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Boston Scientific Corporation (US) Business Overview
Table 53. Boston Scientific Corporation (US) External Neuromodulation SWOT Analysis
Table 54. Boston Scientific Corporation (US) Recent Developments
Table 55. St. Jude Medical, Inc. (US) External Neuromodulation Basic Information
Table 56. St. Jude Medical, Inc. (US) External Neuromodulation Product Overview
Table 57. St. Jude Medical, Inc. (US) External Neuromodulation Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. St. Jude Medical, Inc. (US) External Neuromodulation SWOT Analysis
Table 59. St. Jude Medical, Inc. (US) Business Overview
Table 60. St. Jude Medical, Inc. (US) Recent Developments
Table 61. Synapse Biomedical, Inc. (US) External Neuromodulation Basic Information
Table 62. Synapse Biomedical, Inc. (US) External Neuromodulation Product Overview
Table 63. Synapse Biomedical, Inc. (US) External Neuromodulation Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Synapse Biomedical, Inc. (US) Business Overview
Table 65. Synapse Biomedical, Inc. (US) Recent Developments
Table 66. Nevro Corporation (US) External Neuromodulation Basic Information
Table 67. Nevro Corporation (US) External Neuromodulation Product Overview
Table 68. Nevro Corporation (US) External Neuromodulation Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Nevro Corporation (US) Business Overview
Table 70. Nevro Corporation (US) Recent Developments
Table 71. Neurosigma, Inc. (US) External Neuromodulation Basic Information
Table 72. Neurosigma, Inc. (US) External Neuromodulation Product Overview
Table 73. Neurosigma, Inc. (US) External Neuromodulation Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Neurosigma, Inc. (US) Business Overview
Table 75. Neurosigma, Inc. (US) Recent Developments
Table 76. Neuropace, Inc. (US) External Neuromodulation Basic Information
Table 77. Neuropace, Inc. (US) External Neuromodulation Product Overview
Table 78. Neuropace, Inc. (US) External Neuromodulation Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Neuropace, Inc. (US) Business Overview
Table 80. Neuropace, Inc. (US) Recent Developments
Table 81. Neuronetics, Inc. (US) External Neuromodulation Basic Information
Table 82. Neuronetics, Inc. (US) External Neuromodulation Product Overview
Table 83. Neuronetics, Inc. (US) External Neuromodulation Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Neuronetics, Inc. (US) Business Overview
Table 85. Neuronetics, Inc. (US) Recent Developments
Table 86. Cyberonics, Inc. (US) External Neuromodulation Basic Information
Table 87. Cyberonics, Inc. (US) External Neuromodulation Product Overview
Table 88. Cyberonics, Inc. (US) External Neuromodulation Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Cyberonics, Inc. (US) Business Overview
Table 90. Cyberonics, Inc. (US) Recent Developments
Table 91. BioControl Medical (Israel) External Neuromodulation Basic Information
Table 92. BioControl Medical (Israel) External Neuromodulation Product Overview
Table 93. BioControl Medical (Israel) External Neuromodulation Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. BioControl Medical (Israel) Business Overview
Table 95. BioControl Medical (Israel) Recent Developments
Table 96. Global External Neuromodulation Sales Forecast by Region (2025-2030) & (K Units)
Table 97. Global External Neuromodulation Market Size Forecast by Region (2025-2030) & (M USD)
Table 98. North America External Neuromodulation Sales Forecast by Country (2025-2030) & (K Units)
Table 99. North America External Neuromodulation Market Size Forecast by Country (2025-2030) & (M USD)
Table 100. Europe External Neuromodulation Sales Forecast by Country (2025-2030) & (K Units)
Table 101. Europe External Neuromodulation Market Size Forecast by Country (2025-2030) & (M USD)
Table 102. Asia Pacific External Neuromodulation Sales Forecast by Region (2025-2030) & (K Units)
Table 103. Asia Pacific External Neuromodulation Market Size Forecast by Region (2025-2030) & (M USD)
Table 104. South America External Neuromodulation Sales Forecast by Country (2025-2030) & (K Units)
Table 105. South America External Neuromodulation Market Size Forecast by Country (2025-2030) & (M USD)
Table 106. Middle East and Africa External Neuromodulation Consumption Forecast by Country (2025-2030) & (Units)
Table 107. Middle East and Africa External Neuromodulation Market Size Forecast by Country (2025-2030) & (M USD)
Table 108. Global External Neuromodulation Sales Forecast by Type (2025-2030) & (K Units)
Table 109. Global External Neuromodulation Market Size Forecast by Type (2025-2030) & (M USD)
Table 110. Global External Neuromodulation Price Forecast by Type (2025-2030) & (USD/Unit)
Table 111. Global External Neuromodulation Sales (K Units) Forecast by Application (2025-2030)
Table 112. Global External Neuromodulation Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of External Neuromodulation
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global External Neuromodulation Market Size (M USD), 2019-2030
Figure 5. Global External Neuromodulation Market Size (M USD) (2019-2030)
Figure 6. Global External Neuromodulation Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. External Neuromodulation Market Size by Country (M USD)
Figure 11. External Neuromodulation Sales Share by Manufacturers in 2023
Figure 12. Global External Neuromodulation Revenue Share by Manufacturers in 2023
Figure 13. External Neuromodulation Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market External Neuromodulation Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by External Neuromodulation Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global External Neuromodulation Market Share by Type
Figure 18. Sales Market Share of External Neuromodulation by Type (2019-2024)
Figure 19. Sales Market Share of External Neuromodulation by Type in 2023
Figure 20. Market Size Share of External Neuromodulation by Type (2019-2024)
Figure 21. Market Size Market Share of External Neuromodulation by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global External Neuromodulation Market Share by Application
Figure 24. Global External Neuromodulation Sales Market Share by Application (2019-2024)
Figure 25. Global External Neuromodulation Sales Market Share by Application in 2023
Figure 26. Global External Neuromodulation Market Share by Application (2019-2024)
Figure 27. Global External Neuromodulation Market Share by Application in 2023
Figure 28. Global External Neuromodulation Sales Growth Rate by Application (2019-2024)
Figure 29. Global External Neuromodulation Sales Market Share by Region (2019-2024)
Figure 30. North America External Neuromodulation Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America External Neuromodulation Sales Market Share by Country in 2023
Figure 32. U.S. External Neuromodulation Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada External Neuromodulation Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico External Neuromodulation Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe External Neuromodulation Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe External Neuromodulation Sales Market Share by Country in 2023
Figure 37. Germany External Neuromodulation Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France External Neuromodulation Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. External Neuromodulation Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy External Neuromodulation Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia External Neuromodulation Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific External Neuromodulation Sales and Growth Rate (K Units)
Figure 43. Asia Pacific External Neuromodulation Sales Market Share by Region in 2023
Figure 44. China External Neuromodulation Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan External Neuromodulation Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea External Neuromodulation Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India External Neuromodulation Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia External Neuromodulation Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America External Neuromodulation Sales and Growth Rate (K Units)
Figure 50. South America External Neuromodulation Sales Market Share by Country in 2023
Figure 51. Brazil External Neuromodulation Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina External Neuromodulation Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia External Neuromodulation Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa External Neuromodulation Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa External Neuromodulation Sales Market Share by Region in 2023
Figure 56. Saudi Arabia External Neuromodulation Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE External Neuromodulation Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt External Neuromodulation Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria External Neuromodulation Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa External Neuromodulation Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global External Neuromodulation Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global External Neuromodulation Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global External Neuromodulation Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global External Neuromodulation Market Share Forecast by Type (2025-2030)
Figure 65. Global External Neuromodulation Sales Forecast by Application (2025-2030)
Figure 66. Global External Neuromodulation Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of External Neuromodulation
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global External Neuromodulation Market Size (M USD), 2019-2030
Figure 5. Global External Neuromodulation Market Size (M USD) (2019-2030)
Figure 6. Global External Neuromodulation Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. External Neuromodulation Market Size by Country (M USD)
Figure 11. External Neuromodulation Sales Share by Manufacturers in 2023
Figure 12. Global External Neuromodulation Revenue Share by Manufacturers in 2023
Figure 13. External Neuromodulation Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market External Neuromodulation Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by External Neuromodulation Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global External Neuromodulation Market Share by Type
Figure 18. Sales Market Share of External Neuromodulation by Type (2019-2024)
Figure 19. Sales Market Share of External Neuromodulation by Type in 2023
Figure 20. Market Size Share of External Neuromodulation by Type (2019-2024)
Figure 21. Market Size Market Share of External Neuromodulation by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global External Neuromodulation Market Share by Application
Figure 24. Global External Neuromodulation Sales Market Share by Application (2019-2024)
Figure 25. Global External Neuromodulation Sales Market Share by Application in 2023
Figure 26. Global External Neuromodulation Market Share by Application (2019-2024)
Figure 27. Global External Neuromodulation Market Share by Application in 2023
Figure 28. Global External Neuromodulation Sales Growth Rate by Application (2019-2024)
Figure 29. Global External Neuromodulation Sales Market Share by Region (2019-2024)
Figure 30. North America External Neuromodulation Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America External Neuromodulation Sales Market Share by Country in 2023
Figure 32. U.S. External Neuromodulation Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada External Neuromodulation Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico External Neuromodulation Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe External Neuromodulation Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe External Neuromodulation Sales Market Share by Country in 2023
Figure 37. Germany External Neuromodulation Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France External Neuromodulation Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. External Neuromodulation Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy External Neuromodulation Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia External Neuromodulation Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific External Neuromodulation Sales and Growth Rate (K Units)
Figure 43. Asia Pacific External Neuromodulation Sales Market Share by Region in 2023
Figure 44. China External Neuromodulation Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan External Neuromodulation Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea External Neuromodulation Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India External Neuromodulation Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia External Neuromodulation Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America External Neuromodulation Sales and Growth Rate (K Units)
Figure 50. South America External Neuromodulation Sales Market Share by Country in 2023
Figure 51. Brazil External Neuromodulation Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina External Neuromodulation Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia External Neuromodulation Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa External Neuromodulation Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa External Neuromodulation Sales Market Share by Region in 2023
Figure 56. Saudi Arabia External Neuromodulation Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE External Neuromodulation Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt External Neuromodulation Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria External Neuromodulation Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa External Neuromodulation Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global External Neuromodulation Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global External Neuromodulation Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global External Neuromodulation Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global External Neuromodulation Market Share Forecast by Type (2025-2030)
Figure 65. Global External Neuromodulation Sales Forecast by Application (2025-2030)
Figure 66. Global External Neuromodulation Market Share Forecast by Application (2025-2030)